FIELD: chemistry.
SUBSTANCE: pharmaceutical compositions containing at least one compound of formula 
(IIIa) or 
(IIIb) or 
(IVa) or 
(IVb), where -X- and Y are described in the claims, or pharmaceutically acceptable salts, esters or amides thereof and a pharmaceutically acceptable carrier, which can be used in processes with modulation or E- and P-selectin expression.
EFFECT: obtaining low-molecular non-glycoside and non-peptide compounds, capable of creating antagonism to selectin-mediated processes.
11 cl, 38 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL FLOROGLUCIN DERIVATIVES, POSSESSING ACTIVITY WITH RESPECT TO SELECTIN LIGAND | 2006 |
|
RU2418584C2 |
| NOVEL NITROCATECOL DERIVATIVES POSSESSING ACTIVITY AS SELECTIN LIGANDS | 2006 |
|
RU2428979C2 |
| INDOLES USEFUL IN TREATMENT ANDROGEN RECEPTORS BOUND DESEASES | 2003 |
|
RU2328484C2 |
| PYRAZINE DERIVATIVES USED AS ATR KINASE INHIBITORS | 2009 |
|
RU2604066C2 |
| PROLYL HYDROXYLASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2429226C9 |
| DERIVATIVES OF TAXANE FUNCTIONED BY POSITION 14 AND METHOD FOR THEIR PREPARING | 2003 |
|
RU2320652C2 |
| NEW COMPOUNDS AND COMPOSITIONS FOR CATHEPSIN INHIBITION | 2004 |
|
RU2346943C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| PAN-GENOMIC INHIBITORS OF THE HEPATITIS C VIRUS PROTEIN NS5A, PHARMACEUTICAL COMPOSITIONS, INTERMEDIATES FOR THE SYNTHESIS OF INHIBITORS, AND METHODS FOR THEIR PREPARATION AND USE | 2016 |
|
RU2669919C1 |
| HALOGEN SUBSTITUTED HETEROCYCLIC COMPOUND | 2013 |
|
RU2649398C2 |
